Advertisement
Screener

FORTE BIOSCIENCES, INC. (FBRX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

2.8 / 5 stars · 68/120 Roast Me

FORTE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

FORTE BIOSCIENCES, INC. (FBRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 75.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12

  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 75.00K shares.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 75.96K shares, a 3698.15% increase year-over-year.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 82.89K shares.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 169.56K shares, a 903.91% increase from fiscal 2024.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 16.89K shares, a 73.16% decline from fiscal 2023.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 62.92K shares, a 45.89% decline from fiscal 2022.
  • FORTE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 116.27K shares, a 69.32% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
75.00K shares
10-Q · filed 2026-08-12
150.96K shares
derived: sum of 3 quarters · filed 2026-08-12
233.86K shares
derived: sum of 4 quarters · filed 2026-08-12
2026-03-3175.00K shares
10-Q · filed 2026-05-11
150.96K shares
derived: sum of 2 quarters · filed 2026-05-11
233.86K shares
derived: sum of 3 quarters · filed 2026-05-11
2025-12-3175.96K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
158.86K shares
derived: sum of 2 quarters · filed 2026-03-31
169.56K shares
10-K · filed 2026-03-31
2025-09-3082.89K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
93.60K shares
10-Q · filed 2025-11-14
2025-06-3010.71K shares
10-Q · filed 2025-08-14
2024-12-312.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
-355.46K shares
derived: sum of 2 quarters · filed 2025-03-28
-140.82K shares
derived: sum of 3 quarters · filed 2025-03-28
16.89K shares
10-K · filed 2025-03-28
2024-09-30-357.46K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-142.82K shares
derived: sum of 2 quarters · filed 2024-11-14
14.89K shares
10-Q · filed 2024-11-14
2024-06-30214.65K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
372.35K shares
10-Q · filed 2024-08-14
2024-03-31157.71K shares
10-Q · filed 2024-05-13
2023-12-3162.92K shares
10-K · filed 2024-03-18
2022-12-3116.72K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
25.54K shares
derived: sum of 2 quarters · filed 2023-03-31
65.54K shares
derived: sum of 3 quarters · filed 2023-03-31
116.27K shares
10-K · filed 2023-03-31
2022-09-308.82K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
48.82K shares
derived: sum of 2 quarters · filed 2022-11-14
99.55K shares
10-Q · filed 2022-11-14
327.41K shares
derived: sum of 4 quarters · filed 2022-11-14
2022-06-3040.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
90.73K shares
10-Q · filed 2022-08-15
318.59K shares
derived: sum of 3 quarters · filed 2022-08-15
350.25K shares
derived: sum of 4 quarters · filed 2022-08-15
2022-03-3150.73K shares
10-Q · filed 2022-05-16
278.59K shares
derived: sum of 2 quarters · filed 2022-05-16
310.25K shares
derived: sum of 3 quarters · filed 2022-05-16
349.75K shares
derived: sum of 4 quarters · filed 2022-05-16
2021-12-31227.86K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
259.53K shares
derived: sum of 2 quarters · filed 2022-03-31
299.02K shares
derived: sum of 3 quarters · filed 2022-03-31
379.02K shares
10-K · filed 2022-03-31
2021-09-3031.67K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
71.17K shares
derived: sum of 2 quarters · filed 2021-11-08
151.16K shares
10-Q · filed 2021-11-08
151.16K shares
derived: sum of 4 quarters · filed 2021-11-08
2021-06-3039.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
119.50K shares
10-Q · filed 2021-08-16
119.50K shares
derived: sum of 3 quarters · filed 2021-08-16
2021-03-3180.00K shares
10-Q · filed 2021-05-10
80.00K shares
derived: sum of 2 quarters · filed 2021-05-10
2020-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
166.00 shares
10-K · filed 2021-03-16
2020-09-30166.00 shares
10-Q · filed 2020-11-09